Specialty Rheumatology, Allergy and Immunology
-
Featured
Study Seeks FDA-approved Therapy for IgG4-related Disease
Massachusetts General Hospital is conducting an NIH-funded clinical trial exploring elotuzumab as a treatment for IgG4-related disease.
-
Featured
Severe Allergic Reactions Are Rare with COVID-19 mRNA Vaccines
A prospective study of employee mRNA COVID-19 vaccination at Mass General Brigham linked self-reported history of high-risk allergy to increased risk of self-reported allergic reactions, but only 0.3% of employees had severe reactions and the vast majority completed the two-dose series.
-
Rheumatoid Arthritis Tied to Increased Risk of Contracting COVID-19
Yuqing Zhang, DSc, and colleagues in the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital found the incidence of COVID-19 is higher among patients with rheumatoid arthritis than in the general population, regardless of medication use and multiple other potential confounders.
-
Anti-CD20 Monoclonal Antibody Therapy for Immune-mediated Diseases Increases Risk of Death from COVID-19
Zachary S. Wallace, MD, MSc, Naomi J. Patel, MD, and colleagues determined retrospectively that the risk of death from COVID-19 is twice as high in patients who use anti-CD20 monoclonal antibodies for the treatment of immune-mediated diseases versus COVID-19 patients in the general population.
-
Review: Cardiometabolic–Renal Comorbidities in Gout
Hyon K. Choi, MD, Chio Yokose, MD, MS, and Natalie McCormick, PhD, of the Division of Rheumatology, Allergy and Immunology, suggest pharmacologic agents that can both lower urate levels in patients with gout and treat common cardiometabolic-renal comorbidities of the disease.
-
Inflammatory Vaginitis in Women on Long-Term Rituximab for Autoimmune Disorders
Caroline M. Mitchell, MD, director of the Vulvovaginal Disorders Program in the Department of Obstetrics & Gynecology, and colleagues have described refractory inflammatory vaginitis as a debilitating potential side effect of long-term B-cell depletion with rituximab.
Rheumatology, Allergy and Immunology Contributors
-
Andrew D. Luster, MD, PhD
Chief of the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Director of the Center for Immunology and Inflammatory Diseases
Recent Article
The Role of Atypical Chemoattractant Receptors in Recruiting Neutrophils into Inflamed Tissue Sites
-
Hak Soo Choi, PhD
Director, Bioengineering and Nanomedicine Program, Massachusetts General Hospital, Associate Professor of Radiology, Harvard Medical School, Faculty, Dana-Farber/Harvard Cancer Center
Recent Article
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis -
Hyon Choi, MD
Program Director, Clinical Epidemiology Program, Massachusetts General Hospital, Clinical Rheumatologist, Department of Medicine
Recent Article
Review: Cardiometabolic–Renal Comorbidities in Gout
-
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
Initiate Weekly Tocilizumab As Soon As Possible in Giant Cell Arteritis
-
Kimberly G. Blumenthal, MD, MSc
Quality and Safety Officer for Allergy, Massachusetts General Hospital, Co-Director, Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology
Recent Article
Hospitalized Pneumonia Patients Who Have Unconfirmed Penicillin/Cephalosporin Allergy Likely to Receive Suboptimal Treatment
-
Wayne G. Shreffler, MD, PhD
Chief, Pediatric Allergy & Immunology, Director, Food Allergy Center, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
Key Allergic Mediators of Eosinophilic Esophagitis Identified -
Yuqing Zhang, DSc
Director of Epidemiological and Biostatistical Methods, Rheumatology Unit, Massachusetts General Hospital, Professor in Residence in Medicine, Harvard Medical School
Recent Article
Rheumatoid Arthritis Tied to Increased Risk of Contracting COVID-19 -
Zachary S. Wallace, MD, MSc
Physician, Rheumatology Unit, Massachusetts General Hospital
Recent Article
Anti-CD20 Monoclonal Antibody Therapy for Immune-mediated Diseases Increases Risk of Death from COVID-19
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.